LAVA Therapeutics NV LVTX 深 沪
已收盘 09-12 16:00:00 美东时间
1.545
+0.005
+0.32%
华盛通- 最 高1.5554
- 今 开1.54
- 成交量 5.72万股
- 最 低 1.53
- 昨 收 1.54
- 总市值 4064.17万
- 52周最高 2.093
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 0.8502
- 委 比 87.41%
- 总股本 2630.53万
- 历史最高 17.20
- 量 比 1.04
- 振 幅 1.65%
- 历史最低 0.8502
- 每 手 1
- 风险率 0.59%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多4 Biotech Stocks That Are Showing Weakness: Momentum Scores Fading Over The Past Week
Several biotech stocks have seen their strength fade over the past week, with their Momentum scores in Benzinga's Edge Stock Rankings witnessing a significant decline.
09-03 18:21
美股大行评级 | 潜在涨幅345.51%！BTIG上调Syndax Pharmaceuticals目标价至56美元，维持"买入"评级
今日重点评级关注：BTIG：维持Syndax Pharmaceuticals"买入"评级，目标价从43美元升至56美元；花旗：维持Syndax Pharmaceuticals"买入"评级，目标价从46美元升至51美元
08-06 09:30
Jefferies Downgrades LAVA Therapeutics to Hold, Lowers Price Target to $1.5
Jefferies analyst Roger Song downgrades LAVA Therapeutics (NASDAQ:LVTX) from Buy to Hold and lowers the price target from $3 to $1.5.
08-05 18:43
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SCS, HNI, LVTX, HLVX on Behalf of Shareholders
NEW YORK, Aug. 4, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or ...
08-05 00:23
LAVA Therapeutics Agrees to Acquisition by XOMA
The latest announcement is out from LAVA Therapeutics ( ($LVTX) ). On August 3,...
08-04 19:58
JMP Securities Reiterates Market Perform on LAVA Therapeuticsto Market Perform
JMP Securities analyst Reni Benjamin reiterates LAVA Therapeutics (NASDAQ:LVTX) from Market Perform to Market Perform.
05-15 22:08
LAVA Therapeutics Q1 EPS $(0.13) Beats $(0.38) Estimate
LAVA Therapeutics (NASDAQ:LVTX) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.38) by 65.79 percent. This is a 550 percent decrease over losses of $(0.02) per share from
05-14 19:40
美股大行评级 | 潜在涨幅778.38%！HC Wainwright & Co.上调BioLine Rx目标价至26美元，维持"买入"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1113752959213998081.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• HC Wainwright & Co.：维持BioLine Rx(BLRX)"买入"评级，目标价从9美元升至26美元</p> <p>• 德银：上调固特异轮胎橡胶(GT)评级至"买入"，目标价13美元</p> <p
04-01 09:48
Analyst Downgrades LAVA Therapeutics, Sees Pipeline Overhang
LAVA Therapeutics reviews strategic options amid cost cuts. HC Wainwright downgrades stock, citing uncertainties over LAVA-1266 and possible business shifts.
03-01 01:32
美股大行评级 | Susquehanna：维持AerCap Holdings"积极"评级，目标价从108美元升至120美元
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1102154574572916737.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Piper Sandler：维持Prothena Corp(PRTA)"超配"评级，目标价从94美元升至110美元</p> <p>• Stifel：维持GH Research(GHRS)"买入"评级，目标价从18美元升至3
02-28 09:50
